Glow LifeTech Corp.: Glow LifeTech Announces Successful First Commercial Production of ArtemiC for Global Distributor and a Second Production Scaled to Meet Growing Global Demand Glow" or the " Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce the successful delivery of the first commercial production run of ArtemiC at its supply partner, Swiss PharmaCan AG ("SPC") in April 2021 1, and a second production run worth nearly $1 million 2 CAD that is scaled to service the growing demand around the world. Glow ArtemiC https://orders.newsfilecorp.com/files/3920/82873_9c83b087946a5903_001full.jpg Building on the Company's recent application to Health Canada for its natural oral spray, ArtemiC, following its successful COVID-19 Phase II clinical trial (see Glow's release dated April 27, 2021), the Company's strategic focus is on expediting the launch of ArtemiC in Canada and beyond as cases of COVID-19 are spiking globally, with some countries seeing record numbers of daily cases as new variants circulate widely and vaccine shortages prohibit widespread access.